BiotechTube
Home/Innovent Biologics/Mr. Frank Wang
MF

Mr. Frank Wang

Chief Financial Officer

Innovent Biologics

Therapeutic Areas

OncologyMetabolic DisordersAutoimmune Diseases

Innovent Biologics Pipeline

DrugIndicationPhase
Tyvyt (sintilimab)Various CancersApproved
Byvasda (bevacizumab biosimilar)Various CancersApproved
IBI-306HypercholesterolemiaNDA Submitted
IBI-362Type 2 Diabetes/ObesityPhase 3
IBI-310Various CancersPhase 3
IBI-326Multiple MyelomaPhase 1/2
IBI-322Advanced Solid TumorsPhase 1/2
IBI-323Advanced Solid TumorsPhase 1/2

Leadership Team at Innovent Biologics

DM
Dr. Michael Yu (Dezheng Yu)
Founder, Chairman, CEO & President
DH
Dr. Hui Zhou
Chief Scientific Officer
DL
Dr. Lei Qian
Chief Medical Officer
MA
Ms. Amy Chen
Senior Vice President, Commercial Operations
View full Innovent Biologics profile